Pfizer, Merck drop after Wall Street downgrades on 'patent cliff' and competition
January 23, 2019 at 08:34 AM EST
Shares of Pfizer and Merck fell on Wednesday after Wall Street downgraded the drugmakers on increased competition and the loss of patent protection.
